G  	G  	 NNP	B-NP
protein  	protein  	 NN	I-NP
regulation  	regulation  	 NN	I-NP
of  	of  	 IN	I-NP
neuronal  	neuronal  	 JJ	I-NP
calcium  	calcium  	 NN	I-NP
channels 	channels 	 NNS	I-NP
:  	:  	 :	O
back  	back  	 RB	O
to  	to  	 TO	O
the  	the  	 DT	O
future  	future  	 JJ	O
Neuronal  	Neuronal  	 JJ	B-NP
voltage-gated  	voltage-gated  	 JJ	I-NP
calcium  	calcium  	 NN	I-NP
channels  	channels  	 NNS	I-NP
have  	have  	 VBP	O
evolved  	evolved  	 VBN	O
as  	as  	 IN	O
one  	one  	 CD	O
of  	of  	 IN	O
the  	the  	 DT	O
most  	most  	 RBS	O
important  	important  	 JJ	O
players  	players  	 NNS	O
for  	for  	 IN	O
calcium  	calcium  	 JJ	B-NP
entry  	entry  	 NN	I-NP
into  	into  	 IN	O
presynaptic  	presynaptic  	 JJ	B-NP
endings  	endings  	 JJ	I-NP
responsible  	responsible  	 JJ	O
for  	for  	 IN	O
the  	the  	 DT	O
release  	release  	 NN	O
of  	of  	 IN	O
neurotransmitters 	neurotransmitters 	 NN	B-NP
.  	.  	 .	O
In  	In  	 IN	O
turn 	turn 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
to  	to  	 TO	O
fine-tune  	fine-tune  	 JJ	B-NP
synaptic  	synaptic  	 JJ	I-NP
activity  	activity  	 NN	I-NP
and  	and  	 CC	O
neuronal  	neuronal  	 JJ	B-NP
communication 	communication 	 NN	I-NP
,  	,  	 ,	O
numerous  	numerous  	 JJ	B-NP
neurotransmitters  	neurotransmitters  	 NNS	I-NP
exert  	exert  	 VBP	O
a  	a  	 DT	O
potent  	potent  	 JJ	O
negative  	negative  	 JJ	B-NP
feedback  	feedback  	 NN	I-NP
over  	over  	 IN	O
the  	the  	 DT	O
calcium  	calcium  	 JJ	B-NP
signal  	signal  	 NN	I-NP
provided  	provided  	 VBN	O
by  	by  	 IN	O
G  	G  	 NNP	O
protein-coupled  	protein-coupled  	 JJ	O
receptors 	receptors 	 NNS	B-NP
.  	.  	 .	O
This  	This  	 DT	O
regulation  	regulation  	 NN	B-NP
pathway  	pathway  	 NN	I-NP
of  	of  	 IN	I-NP
physiologic  	physiologic  	 JJ	I-NP
importance  	importance  	 NN	I-NP
is  	is  	 VBZ	O
also  	also  	 RB	O
extensively  	extensively  	 RB	O
exploited  	exploited  	 VBN	O
for  	for  	 IN	O
therapeutic  	therapeutic  	 JJ	B-NP
purposes 	purposes 	 NNS	I-NP
,  	,  	 ,	O
for  	for  	 IN	O
instance  	instance  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
neuropathic  	neuropathic  	 JJ	B-NP
pain  	pain  	 NN	I-NP
by  	by  	 IN	O
morphine  	morphine  	 NN	O
and  	and  	 CC	O
other  	other  	 JJ	O
μ-opioid  	μ-opioid  	 JJ	B-NP
receptor  	receptor  	 NN	I-NP
agonists 	agonists 	 NN	I-NP
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
despite  	despite  	 IN	O
more  	more  	 JJR	O
than  	than  	 IN	O
three  	three  	 CD	O
decades  	decades  	 NNS	O
of  	of  	 IN	O
intensive  	intensive  	 JJ	B-NP
research 	research 	 NN	I-NP
,  	,  	 ,	O
important  	important  	 JJ	O
questions  	questions  	 NNS	O
remain  	remain  	 VBP	O
unsolved  	unsolved  	 VBN	O
regarding  	regarding  	 VBG	O
the  	the  	 DT	O
molecular  	molecular  	 JJ	O
and  	and  	 CC	O
cellular  	cellular  	 JJ	B-NP
mechanisms  	mechanisms  	 NNS	I-NP
of  	of  	 IN	O
direct  	direct  	 JJ	O
G  	G  	 NNP	B-NP
protein  	protein  	 NN	I-NP
inhibition  	inhibition  	 NN	I-NP
of  	of  	 IN	O
voltage-gated  	voltage-gated  	 JJ	O
calcium  	calcium  	 NN	O
channels 	channels 	 NNS	O
.  	.  	 .	O
In  	In  	 IN	O
this  	this  	 DT	O
study 	study 	 NN	O
,  	,  	 ,	O
we  	we  	 PRP	O
revisit  	revisit  	 VB	O
this  	this  	 DT	O
particular  	particular  	 JJ	O
regulation  	regulation  	 NN	O
and  	and  	 CC	O
explore  	explore  	 VB	O
new  	new  	 JJ	O
considerations 	considerations 	 NNS	B-NP
.  	.  	 .	O
